Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene Symbol | VHL | ||||||||||
Synonyms | HRCA1 | pVHL | RCA1 | VHL1 | ||||||||||
Gene Description | VHL, von Hippel-Lindau tumor suppressor, is part of an E3 ubiquitin protein ligase complex, which promotes degradation of HIF-alpha and other protein targets required for cellular growth and angiogenesis (PMID: 24583008, PMID: 30194449), and plays a role in genomic stability (PMID: 31747945). VHL contributes to von Hippel-Lindau disease (PMID: 30194449, PMID: 30006056) and sporadic tumors, including clear cell renal carcinoma (PMID: 24583008, PMID: 30149673). | ||||||||||
ACMG Incidental List v3.0: |
|
||||||||||
|
Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|---|---|---|---|
A149D | missense | unknown | VHL A149D lies within the CCT complex-binding region of the Vhl protein (UniProt.org). A149D has been identified in the scientific literature (PMID: 19996202), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, May 2024). | |
A149T | missense | unknown | VHL A149T lies within the CCT complex-binding region of the Vhl protein (UniProt.org). A149T demonstrates HIFa and its target gene regulation, cell cycle exit, and spheroid formation to similar levels of wild-type VHL in culture (PMID: 17526729), but also results in reduced binding to Hif1a and ubiquitination (PMID: 11865071), and therefore, its effect on Vhl protein function is unknown. | |
amp | none | no effect | VHL amplification indicates an increased number of copies of the VHL gene. However, the mechanism causing the increase is unspecified. | |
C162* | nonsense | loss of function - predicted | VHL C162* results in a premature truncation of the Vhl protein at amino acid 162 of 213 (UniProt.org). C162* has not been characterized, however, due to the effects of other truncation mutations downstream of C162 (PMID: 14691445), is predicted to lead to a loss of Vhl protein function. | |
C162F | missense | loss of function | VHL C162F lies within the Elongin BC complex-interacting region of the Vhl protein (UniProt.org). C162F leads to a loss of Vhl function as indicated by failure to bind to Elongin BC complex and inhibition of ubiquitin-dependent proteolysis in cell culture (PMID: 9447969, PMID: 11331612). | |
C162R | missense | unknown | VHL C162R lies within the Elongin BC complex-interacting region of the Vhl protein (UniProt.org). C162R has been identified in the scientific literature (PMID: 27530247, PMID: 27034166, PMID: 38619811), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, May 2024). | |
C162W | missense | loss of function - predicted | VHL C162W lies within the Elongin BC complex-interacting region of the Vhl protein (UniProt.org). C162W is predicted to confer a loss of function to the Vhl protein, as indicated by failure to induce protein ubiquitination in culture (PMID: 17350623). | |
C162Y | missense | unknown | VHL C162Y lies within the Elongin BC complex-interacting region of the Vhl protein (UniProt.org). C162Y has been identified in the scientific literature (PMID: 23797736, PMID: 17264095), but has not been biochemically characterized and therefore, its effect on VHL protein function is unknown (PubMed, Apr 2024). | |
C77* | nonsense | loss of function - predicted | VHL C77* results in a premature truncation of the Vhl protein at amino acid 77 of 213 (UniProt.org). C77* has not been characterized, however, due to the effects of other truncation mutations downstream of C77 (PMID: 14691445), is predicted to lead to a loss of Vhl protein function. | |
D121G | missense | loss of function - predicted | VHL D121G lies within the CCT complex-binding region of the Vhl protein (UniProt.org). D121G retains interaction with Cul2, Roc1, Elongin B, and Hif1/2 in culture (PMID: 11865071, PMID: 17967880, PMID: 19030229), however, results in decreased binding to Elongin C (PMID: 19030229, PMID: 11865071) and impaired Vhl nuclear export and degradation of Hif2a in culture (PMID: 17967880), and therefore, is predicted to lead to a loss of Vhl protein function. | |
D121V | missense | unknown | VHL D121V lies within the CCT complex-binding region of the Vhl protein (UniProt.org). D121V has been identified in sequencing studies (PMID: 28188106), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, Jun 2024). | |
D121Y | missense | unknown | VHL D121Y lies within the CCT complex-binding region of the Vhl protein (UniProt.org). D121Y has been identified in sequencing studies (PMID: 24504440), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, May 2024). | |
D126N | missense | loss of function | VHL D126N lies within the CCT complex-binding region of the Vhl protein (UniProt.org). D126N confers a loss of function to the Vhl protein as indicated by decreased Vhl protein stability, impaired ability to regulate Hif1a degradation, and increased expression of Hif1a target genes in cultured cells (PMID: 21454469). | |
del | deletion | loss of function | VHL del indicates a deletion of the VHL gene. | |
E173D | missense | unknown | VHL E173D does not lie within any known functional domains of the Vhl protein (UniProt.org). E173D has not been characterized in the scientific literature and therefore, its effect on Vhl protein function is unknown (PubMed, Apr 2024). | |
E186K | missense | unknown | VHL E186K does not lie within any known functional domains of the Vhl protein (UniProt.org). E186K has been identified in the scientific literature (PMID: 28753842), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, May 2024). | |
E52fs | frameshift | loss of function - predicted | VHL E52fs results in a change in the amino acid sequence of the Vhl protein beginning at aa 52 of 213, likely resulting in premature truncation of the functional protein (UniProt.org). E52fs has not been characterized, however, due to the effects of other truncation mutations downstream of E52 (PMID: 14691445), is predicted to lead to a loss of Vhl protein function. | |
E70* | nonsense | loss of function - predicted | VHL E70* results in a premature truncation of the Vhl protein at amino acid 70 of 213 (UniProt.org). E70* has not been characterized, however, due to the effects of other truncation mutations downstream of E70 (PMID: 14691445), is predicted to lead to a loss of Vhl protein function. | |
E70_R79dup | duplication | unknown | VHL E70_R79dup indicates the insertion of ten duplicate amino acids, glutamic acid (E)-70 through arginine (R)-79, in the Vhl protein (UniProt.org). E70_R79dup has not been characterized in the scientific literature and therefore, its effect on Vhl protein function is unknown (PubMed, Jun 2024). | |
F119L | missense | loss of function | VHL F119L lies within the CCT complex-binding region and the aromatic tetrahedron core domain of the Vhl protein (UniProt.org, PMID: 23840444). F119L results in decreased Vhl protein stability as compared to wild-type, demonstrating increased misfolding and aggregation of Vhl protein in in-vitro assays (PMID: 23840444), and reduced solubility and decreased binding to Hif1a protein, and overexpression of P119L leads to a lethal phenotype in animal models (PMID: 30194449). | |
F136L | missense | loss of function | VHL F136L lies within the CCT complex-binding region and the aromatic tetrahedron core domain of the Vhl protein (UniProt.org, PMID: 23840444). F136L results in decreased Vhl protein stability as compared to wild-type, demonstrating increased misfolding and aggregation of Vhl protein in in-vitro assays (PMID: 23840444), and reduced solubility and decreased binding to Hif1a protein, and overexpression of P136L leads to a lethal phenotype in animal models (PMID: 30194449). | |
F148fs | frameshift | loss of function - predicted | VHL F148fs results in a change in the amino acid sequence of the Vhl protein beginning at aa 148 of 213, likely resulting in premature truncation of the functional protein (UniProt.org). F148fs has not been characterized, however, due to the effects of other truncation mutations downstream of F148 (PMID: 14691445), is predicted to lead to a loss of Vhl protein function. | |
F148Lfs*11 | frameshift | loss of function - predicted | VHL F148Lfs*11 indicates a shift in the reading frame starting at amino acid 148 and terminating 11 residues downstream causing a premature truncation of the 213 amino acid Vhl protein (UniProt.org). F148Lfs*11 has not been characterized, however, due to the effects of other truncation mutations downstream of F148 (PMID: 14691445), is predicted to lead to a loss of Vhl protein function. | |
F76Afs*80 | frameshift | loss of function - predicted | VHL F76Afs*80 indicates a shift in the reading frame starting at amino acid 76 and terminating 80 residues downstream causing a premature truncation of the 213 amino acid Vhl protein (UniProt.org). F76Afs*80 has not been characterized, however, due to the effects of other truncation mutations downstream of F76 (PMID: 14691445), is predicted to lead to a loss of Vhl protein function. | |
F76del | deletion | loss of function | VHL F76del results in the deletion of an amino acid of the Vhl protein at amino acid 76 (UniProt.org). F76del results in a loss of Vhl protein function, as indicated by loss of binding to p220/240, HIF-1alpha, HIF-2alpha, and ElonginC and loss of normoxic suppression of HIF-2alpha in cell culture (PMID: 11331613). | |
F76S | missense | unknown | VHL F76S does not lie within any known functional domains of the Vhl protein (UniProt.org). F76S has been identified in the scientific literature (PMID: 18836774, PMID: 24166983), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, Apr 2024). | |
F91L | missense | loss of function - predicted | VHL F91L does not lie within any known functional domains of the Vhl protein (UniProt.org). F91L results in impaired binding to Hif1a and Hif2a in an in vitro assay (PMID: 31337753), and therefore, is predicted to lead to a loss of Vhl protein function. | |
G106V | missense | unknown | VHL G106V lies within the CCT complex-binding region of the Vhl protein (UniProt.org). G106V has not been characterized in the scientific literature and therefore, its effect on Vhl protein function is unknown (PubMed, Apr 2024). | |
G114A | missense | unknown | VHL G114A lies within the CCT complex-binding region of the Vhl protein (UniProt.org). G114A has been identified in sequencing studies (PMID: 26342236), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, Jun 2024). | |
G114C | missense | unknown | VHL G114C lies within the CCT complex-binding region of the Vhl protein (UniProt.org). G114C has been identified in the scientific literature (PMID: 27845047, PMID: 27530247, PMID: 18836774), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, May 2024). | |
G114R | missense | loss of function - predicted | VHL G114R lies within the CCT complex-binding region of the Vhl protein (UniProt.org). G114R is predicted to confer a loss of function to the Vhl protein as indicated by failure to bind to Elongin BC complex and TriC in cell culture (PMID: 14636579). | |
G123W | missense | unknown | VHL G123W lies within the CCT complex-binding region of the Vhl protein (UniProt.org). G123W has not been characterized in the scientific literature and therefore, its effect on Vhl protein function is unknown (PubMed, Apr 2024). | |
G127V | missense | unknown | VHL G127V lies within the CCT complex-binding region of the Vhl protein (UniProt.org). G127V has been identified in sequencing studies (PMID: 22895193), but has not been biochemically characterized and therefore, its effect on VHL protein function is unknown (PubMed, Apr 2024). | |
G144A | missense | unknown | VHL G144A lies within the CCT complex-binding region of the Vhl protein (UniProt.org). G144A has been not been characterized in the scientific literature and therefore, its effect on VHL protein function is unknown (PubMed, Apr 2024). | |
G144E | missense | unknown | VHL G144E lies within the CCT complex-binding region of the Vhl protein (UniProt.org). G144E has been identified in sequencing studies (PMID: 27998968), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, Apr 2024). | |
G144fs | frameshift | loss of function - predicted | VHL G144fs results in a change in the amino acid sequence of the Vhl protein beginning at aa 144 of 213, likely resulting in premature truncation of the functional protein (UniProt.org). G144fs has not been characterized, however, due to the effects of other truncation mutations downstream of G144 (PMID: 14691445), is predicted to lead to a loss of Vhl protein function. | |
G29D | missense | unknown | VHL G29D within the pentameric repeat region of the Vhl protein (UniProt.org). G29D has been identified in sequencing studies (PMID: 22895193), but has not been biochemically characterized and therefore, its effect on VHL protein function is unknown (PubMed, Apr 2024). | |
G39D | missense | unknown | VHL G39D lies within the pentameric repeat region of the Vhl protein (UniProt.org). G39D has been identified in the scientific literature (PMID: 23558940), but has not been biochemically characterized and therefore, its effect on VHL protein function is unknown (PubMed, Apr 2024). | |
G93V | missense | unknown | VHL G93V does not lie within any known functional domains of the Vhl protein (UniProt.org). G93V has been identified in the scientific literature (PMID: 24969085, Journal of Clinical Oncology 28, no. 15_suppl e15024), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, Apr 2024). | |
H110L | missense | unknown | VHL H110L lies within the CCT complex-binding region of the Vhl protein (UniProt.org). H110L has been identified in the scientific literature (PMID: 36329119), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, Apr 2024). | |
H110Q | missense | unknown | VHL H110Q lies within the CCT complex-binding region of the Vhl protein (UniProt.org). H110Q has been identified in the scientific literature (PMID: 12781449), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, Apr 2024). | |
H115N | missense | unknown | VHL H115N lies within the CCT complex-binding region of the Vhl protein (UniProt.org). H115N has been identified in the scientific literature (PMID: 24446253, PMID: 16488999), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, May 2024). | |
H115Q | missense | loss of function - predicted | VHL H115Q lies within the CCT complex-binding region of the Vhl protein (UniProt.org). H115Q is predicted to confer a loss of function to the Vhl protein, as indicated by decreased binding to Hif1a in cell culture (PMID: 28775317). | |
H115R | missense | unknown | VHL H115R lies within the CCT complex-binding region of the Vhl protein (UniProt.org). H115R results in exon 2 skipping splice variants similar to wild-type (PMID: 36905328) and is predicted to disrupt the Hif1a binding activity of the Vhl protein based on computer modeling (PMID: 22105711), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, Jun 2024). | |
H115Y | missense | unknown | VHL H115Y lies within the CCT complex-binding region of the Vhl protein (UniProt.org). H115Y has been identified in the scientific literature (PMID: 27845047, PMID: 18836774), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, May 2024). | |
I151F | missense | unknown | VHL I151F lies within the CCT complex-binding region of the Vhl protein (UniProt.org). I151F results in decreased half-life compared to wild-type (PMID: 37833251), but has not been fully biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, Apr 2024). | |
I151N | missense | unknown | VHL I151N lies within the CCT complex-binding region of the Vhl protein (UniProt.org). I151N has been identified in the scientific literature (PMID: 29941223), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, Apr 2024). | |
I151S | missense | loss of function - predicted | VHL I151S lies within the CCT complex-binding region of the Vhl protein (UniProt.org). I151S is predicted to confer a loss of function to the Vhl protein, as indicated by failure to bind to Elongin BC complex and TriC in cell culture (PMID: 14636579). | |
I151T | missense | unknown | VHL I151T lies within the CCT complex-binding region of the Vhl protein (UniProt.org). I151T has been identified in sequencing studies (PMID: 24446253, PMID: 24504440, PMID: 23036577), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, May 2024). | |
I180N | missense | unknown | VHL I180N does not lie within any known functional domains of the Vhl protein (UniProt.org). I180N has been identified in the scientific literature (PMID: 25691774, PMID: 35110537), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, Jun 2024). | |
I180V | missense | unknown | VHL I180V does not lie within any known functional domains of the Vhl protein (UniProt.org). I180V has been identified in sequencing studies (PMID: 23606570), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, Apr 2024). | |
I206* | nonsense | loss of function | VHL I206* results in a premature truncation of the Vhl protein at amino acid 206 of 213 (UniProt.org). I206* results in reduced Hif1a binding in low salt conditions and decreased Hif1a ubiquitination efficiency, and leads to increased Hif1a and Glut1 expression levels under hypoxic conditions in cell culture (PMID: 14691445). | |
I75_C77del | deletion | unknown | VHL I75_C77del results in the deletion of three amino acids of the Vhl protein from amino acids 75 to 77 (UniProt.org). I75_C77del has not been characterized in the scientific literature and therefore, its effect on Vhl protein function is unknown (PubMed, Jun 2024). | |
inact mut | unknown | loss of function | VHL inact mut indicates that this variant results in a loss of function of the Vhl protein. However, the specific amino acid change has not been identified. | |
K171G | missense | loss of function | VHL K171G does not lie within any known functional domains of the Vhl protein (UniProt.org). K171G confers a loss of function to the Vhl protein as demonstrated by decreased Vhl sumoylation, aberrant Vhl localization, decreased association with Alix and Endobrevin and decreased localization of Alix and Endobrevin to the spindle midbody, increase in unresolved cytokinetic bridges, and accumulation of multinucleated cells in culture, and increased tumor formation in mouse models (PMID: 21652636). | |
L101P | missense | unknown | VHL L101P lies within the CCT complex-binding region of the Vhl protein (UniProt.org). L101P has been identified in the scientific literature (PMID: 19996202, PMID: 35469800), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, May 2024). | |
L116fs | frameshift | loss of function - predicted | VHL L116fs results in a change in the amino acid sequence of the Vhl protein beginning at aa 116 of 213, likely resulting in premature truncation of the functional protein (UniProt.org). L116fs has not been characterized, however, due to the effects of other truncation mutations downstream of L116 (PMID: 14691445), is predicted to lead to a loss of Vhl protein function. | |
L128H | missense | unknown | VHL L128H lies within the CCT complex-binding region of the Vhl protein (UniProt.org). L128H has been identified in the scientific literature (PMID: 15956968, PMID: 35110537), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, Jun 2024). | |
L135* | nonsense | loss of function - predicted | VHL L135* results in a premature truncation of the Vhl protein at amino acid 135 of 213 (UniProt.org). L135* has not been characterized, however, due to the effects of other truncation mutations downstream of L135 (PMID: 14691445), is predicted to lead to a loss of Vhl protein function. | |
L135F | missense | unknown | VHL L135F lies within the CCT complex-binding region of the Vhl protein (UniProt.org). L135F has been identified in sequencing studies (PMID: 32217839), but has not been biochemically characterized and therefore, its effect on VHL protein function is unknown (PubMed, Jun 2024). | |
L153P | missense | unknown | VHL L153P lies within the CCT complex-binding region of the Vhl protein (UniProt.org). L153P has been identified in the scientific literature (PMID: 24969085, PMID: 28431395), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, Apr 2024). | |
L158fs | frameshift | loss of function - predicted | VHL L158fs results in a change in the amino acid sequence of the Vhl protein beginning at aa 158 of 213, likely resulting in premature truncation of the functional protein (UniProt.org). L158fs has not been characterized, however, due to the effects of other truncation mutations downstream of L158 (PMID: 14691445), is predicted to lead to a loss of Vhl protein function. | |
L158P | missense | loss of function | VHL L158P lies within the Elongin BC complex-interacting region of the Vhl protein (UniProt.org). L158P leads to decreased binding of Vhl to the Elongin BC complex and failure to activate Hif1a ubiquitination in cell culture (PMID: 10973499). | |
L158Q | missense | loss of function - predicted | VHL L158Q lies within the Elongin BC complex-interacting region of the Vhl protein (UniProt.org). L158Q retains the ability to bind and ubiquitinate Hif1a in an in vitro assay (PMID: 26503325), however, is predicted to lead to a loss of Vhl protein function as demonstrated by decreased Elongin C binding and increased ubiquitination by Ube2s leading to reduced Vhl protein stability and impaired regulation of Hif target genes and cell proliferation in culture (PMID: 26503325). | |
L158S | missense | loss of function | VHL L158S lies within the Elongin BC complex-interacting region of the Vhl protein (UniProt.org). L158S confers a loss of function to the Vhl protein as demonstrated by decreased interaction with Elongin B/C and Cul2, decreased inhibition of Glut1 and Vegf expression under normoxic conditions (PMID: 9447969), and increased Hif2a, Glut1, Junb, and Egln3 levels in cultured cells (PMID: 16098468). | |
L158V | missense | unknown | VHL L158V lies within the Elongin BC complex-interacting region of the Vhl protein (UniProt.org). L158V has been identified in the scientific literature (PMID: 27069690), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, Apr 2024). | |
L163F | missense | unknown | VHL L163F lies within the Elongin BC complex-interacting region of the Vhl protein (UniProt.org). L163F has been identified in the scientific literature (PMID: 17102088, PMID: 32671223), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, Apr 2024). | |
L163P | missense | loss of function - predicted | VHL L163P lies within the Elongin BC complex-interacting region of the Vhl protein (UniProt.org). L163P results in impaired binding to Hif1a in an in vitro assay (PMID: 11986208), and therefore, is predicted to lead to a loss of Vhl protein function. | |
L169P | missense | no effect | VHL L169P does not lie within any known functional domains of the Vhl protein (UniProt.org). L169P retains the ability to degrade Hif1a and results in hypoxia regulation and protein stability similar to wild-type Vhl in culture (PMID: 37069149). | |
L184fs | frameshift | loss of function - predicted | VHL L184fs results in a change in the amino acid sequence of the Vhl protein beginning at aa 184 of 213, likely resulting in premature truncation of the functional protein (UniProt.org). L184fs has not been characterized, however, due to the effects of other truncation mutations downstream of L184 (PMID: 14691445), is predicted to lead to a loss of Vhl protein function. | |
L184P | missense | loss of function - predicted | VHL L184P does not lie within any known functional domains of the Vhl protein (UniProt.org). L184P is predicted to confer a loss of function to the Vhl protein, as indicated by decreased binding to Elongin C and Cul2 in culture (PMID: 28775317). | |
L184R | missense | unknown | VHL L184R does not lie within any known functional domains of the Vhl protein (UniProt.org). L184R has been identified in sequencing studies (PMID: 23036577, PMID: 28481359), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, Apr 2024). | |
L188P | missense | unknown | VHL L188P does not lie within any known functional domains of the Vhl protein (UniProt.org). L188P has been identified in the scientific literature (PMID: 18836774, PMID: 37018064), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, May 2024). | |
L188R | missense | unknown | VHL L188R does not lie within any known functional domains of the Vhl protein (UniProt.org). L188R has been identified in sequencing studies (PMID: 24504440), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, Apr 2024). | |
L188V | missense | loss of function - predicted | VHL L188V does not lie within any known functional domains of the Vhl protein (UniProt.org). L188V demonstrates similar regulation of HIF-alpha, Glut1, and cyclin D1 to wild-type Vhl (PMID: 16452184, PMID: 17526729, PMID: 11331612), and has been demonstrated to both promote (PMID: 16452184) and suppress (PMID: 11331612) tumor formation; however, results in disrupted fibronectin matrix assembly (PMID: 11331612, PMID: 16452184) and elevated Rwdd3 (Rsume), Prkcz (aPKC), and Junb levels in cultured cells (PMID: 16098468, PMID: 30890701), and increased tumor vascularization compared to controls in mouse models (PMID: 16452184), and therefore, is predicted to lead to a loss of Vhl protein function. | |
L198* | nonsense | loss of function | VHL L198* results in a premature truncation of the Vhl protein at amino acid 198 of 213 (UniProt.org). L198* results in reduced Hif1a binding in low salt conditions and decreased Hif1a ubiquitination efficiency, and leads to increased Hif1a and Glut1 expression levels under hypoxic conditions in cell culture (PMID: 14691445). | |
L201P | missense | unknown | VHL L201P does not lie within any known functional domains of the Vhl protein (UniProt.org). L201P has been identified in the scientific literature (PMID: 22895193, PMID: 36936415), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, May 2024). | |
L89H | missense | loss of function - predicted | VHL L89H does not lie within any known functional domains of the Vhl protein (UniProt.org). L89H results in increased expression of Hif1a under both normoxic and hypoxic conditions in cultured cells (PMID: 32234874) and is associated with increased SALL4 gene expression in cell culture (PMID: 32513235), and therefore, is predicted to lead to a loss of Vhl protein function. | |
L89P | missense | unknown | VHL L89P does not lie within any known functional domains of the Vhl protein (UniProt.org). L89P has been identified in the scientific literature (PMID: 18836774, PMID: 28431395, PMID: 37018064), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, May 2024). | |
loss | unknown | loss of function | VHL loss indicates loss of the VHL gene, mRNA and protein. | |
mutant | unknown | unknown | VHL mutant indicates an unspecified mutation in the VHL gene. | |
N131fs | frameshift | loss of function - predicted | VHL N131fs results in a change in the amino acid sequence of the Vhl protein beginning at aa 131 of 213, likely resulting in premature truncation of the functional protein (UniProt.org). N131fs has not been characterized, however, due to the effects of other truncation mutations downstream of N131 (PMID: 14691445), is predicted to lead to a loss of Vhl protein function. | |
N131Y | missense | unknown | VHL N131Y lies within the CCT complex-binding region of the Vhl protein (UniProt.org). N131Y has been identified in the scientific literature (PMID: 24727139, PMID: 29172931, PMID: 26831717), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, May 2024). | |
N78D | missense | unknown | VHL N78D does not lie within any known functional domains of the Vhl protein (UniProt.org). N78D has been identified in the scientific literature (PMID: 23224817), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, May 2024). | |
N78K | missense | unknown | VHL N78K does not lie within any known functional domains of the Vhl protein (UniProt.org). N78K has been identified in sequencing studies (PMID: 23434146, PMID: 11921283, PMID: 38344974), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, Jun 2024). | |
N78S | missense | loss of function | VHL N78S does not lie within any known functional domains of the Vhl protein (UniProt.org). N78S confers a loss of function to the Vhl protein as demonstrated by decreased Vhl protein stability, aberrant cell morphology, and impaired localization of Tjp1 (Zo-1) to tight junctions (PMID: 19602254), failure to regulate Hif1a ubiquitination (PMID: 11331613), and loss of Vdu1 (Usp33) binding in cell culture (PMID: 11739384). | |
N78T | missense | unknown | VHL N78T does not lie within any known functional domains of the Vhl protein (UniProt.org). N78T has been identified in the scientific literature (PMID: 22177731, PMID: 23298237), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, May 2024). | |
N78Y | missense | unknown | VHL N78Y does not lie within any known functional domains of the Vhl protein (UniProt.org). N78Y has been identified in sequencing studies (PMID: 23036577), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, May 2024). | |
N90I | missense | loss of function | VHL N90I does not lie within any known functional domains of the Vhl protein (UniProt.org). N90I confers a loss of function to the Vhl protein as demonstrated by failure to regulate Hif1a ubiquitination and degradation in cultured cells (PMID: 10823831, PMID: 11555645). | |
N90Y | missense | unknown | VHL N90Y does not lie within any known functional domains of the Vhl protein (UniProt.org). N90Y has been identified in sequencing studies (PMID: 24727139), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, May 2024). | |
negative | unknown | loss of function | VHL negative indicates a lack of the VHL gene, mRNA, and/or protein. | |
over exp | none | no effect | VHL over exp indicates an over expression of the Vhl protein. However, the mechanism causing the over expression is unspecified. | |
P154L | missense | loss of function | VHL P154L lies within the CCT complex-binding region of the Vhl protein (UniProt.org). P154L results in a loss of Vhl binding to Tbp-1 and failure to mediate hypoxia-induced Hif1a degradation in culture (PMID: 14556007). | |
P192S | missense | unknown | VHL P192S does not lie within any known functional domains of the Vhl protein (UniProt.org). P192S has been identified in the scientific literature (PMID: 18836774, PMID: 26957611), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, May 2024). | |
P25L | missense | unknown | VHL P25L lies within the pentameric repeat region of the Vhl protein (UniProt.org). P25L has been identified in the scientific literature (PMID: 16884327, PMID: 25803323, PMID: 24727139), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, May 2024). | |
P25S | missense | unknown | VHL P25S lies within the pentameric repeat region of the Vhl protein (UniProt.org). P25S has been identified in the scientific literature (PMID: 22655276), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, Jun 2024). | |
P81S | missense | loss of function | VHL P81S does not lie within any known functional domains of the Vhl protein (UniProt.org). P81S results in a loss of Vhl binding to Tceb1 and failure to regulate Hif1a degradation in culture, and growth advantage in animal tumor models (PMID: 23990666). | |
P81T | missense | unknown | VHL P81T does not lie within any known functional domains of the Vhl protein (UniProt.org). P81T has been identified in sequencing studies (PMID: 21602815), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, May 2024). | |
P86H | missense | loss of function | VHL P86H does not lie within any known functional domains of the Vhl protein (UniProt.org). P86H confers a loss of function to the Vhl protein as demonstrated by failure to suppress GLUT1 expression and impaired regulatory activity of Hif1-alpha (PMID: 10535940). | |
P86L | missense | unknown | VHL P86L does not lie within any known functional domains of the Vhl protein (UniProt.org). P86L has been identified in the scientific literature (PMID: 18836774), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, May 2024). | |
P86R | missense | unknown | VHL P86R does not lie within any known functional domains of the Vhl protein (UniProt.org). P86R has been identified in the scientific literature (PMID: 11257211), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, May 2024). | |
P86S | missense | unknown | VHL P86S does not lie within any known functional domains of the Vhl protein (UniProt.org). P86S has been identified in the scientific literature (PMID: 27057652), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, Oct 2024). | |
P86T | missense | unknown | VHL P86T does not lie within any known functional domains of the Vhl protein (UniProt.org). P86T has been identified in sequencing studies (PMID: 27741505, PMID: 24727139, PMID: 28431395), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, Jun 2024). | |
P95Q | missense | unknown | VHL P95Q does not lie within any known functional domains of the Vhl protein (UniProt.org). P95Q has been identified in sequencing studies (PMID: 29656894), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, May 2024). | |
Q132fs | frameshift | loss of function - predicted | VHL Q132fs results in a change in the amino acid sequence of the Vhl protein beginning at aa 132 of 213, likely resulting in premature truncation of the functional protein (UniProt.org). Q132fs has not been characterized, however, due to the effects of other truncation mutations downstream of Q132 (PMID: 14691445), is predicted to lead to a loss of Vhl protein function. | |
Q164R | missense | loss of function - predicted | VHL Q164R lies within the Elongin BC complex-interacting region of the Vhl protein (UniProt.org). Q164R retains the ability to bind to the Elongin BC complex and ubiquitinate Hif1a in in vitro assays (PMID: 26503325), however, is predicted to lead to a loss of Vhl protein function as demonstrated by increased ubiquitination by Ube2s leading to reduced Vhl protein stability and impaired ability to adequately regulate Hif protein expression and activity in in vitro assays and cell culture (PMID: 26503325). | |
Q195* | nonsense | loss of function | VHL Q195* results in a premature truncation of the Vhl protein at amino acid 195 of 213 (UniProt.org). Q195* results in reduced Hif1a binding in low salt conditions and decreased Hif1a ubiquitination efficiency, and leads to increased Hif1a and Glut1 expression levels under hypoxic conditions in cell culture (PMID: 14691445). | |
Q73E | missense | unknown | VHL Q73E does not lie within any known functional domains of the Vhl1 protein (UniProt.org). Q73E has not been characterized in the scientific literature and therefore, its effect on Vhl protein function is unknown (PubMed, May 2024). | |
Q73H | missense | unknown | VHL Q73H does not lie within any known functional domains of the Vhl1 protein (UniProt.org). Q73H has not been characterized in the scientific literature and therefore, its effect on Vhl protein function is unknown (PubMed, May 2024). | |
Q96* | nonsense | loss of function - predicted | VHL Q96* results in a premature truncation of the Vhl protein at amino acid 96 of 213 (UniProt.org). Q96* has not been characterized, however, due to the effects of other truncation mutations downstream of Q96 (PMID: 14691445), is predicted to lead to a loss of Vhl protein function. | |
R107G | missense | unknown | VHL R107G lies within the CCT complex-binding region of the Vhl protein (UniProt.org). R107G has been identified in the scientific literature (PMID: 18836774), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, May 2024). | |
R107P | missense | unknown | VHL R107P lies within the CCT complex-binding region of the Vhl protein (UniProt.org). R107P has been identified in the scientific literature (PMID: 18836774, PMID: 19996202), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, May 2024). | |
R108del | deletion | unknown | VHL R108del results in the deletion of an amino acid in the CCT complex-binding region of the Vhl protein at amino acid 108 (UniProt.org). R108del has not been characterized in the scientific literature and therefore, its effect on Vhl protein function is unknown (PubMed, Jun 2024). | |
R161* | nonsense | loss of function - predicted | VHL R161* results in a premature truncation of the Vhl protein at amino acid 161 of 213 (UniProt.org). R161* has not been characterized, however, due to the effects of other truncation mutations downstream of R161 (PMID: 14691445), is predicted to lead to a loss of Vhl protein function. | |
R161fs | frameshift | loss of function - predicted | VHL R161fs results in a change in the amino acid sequence of the Vhl protein beginning at aa 161 of 213, likely resulting in premature truncation of the functional protein (UniProt.org). R161fs has not been characterized, however, due to the effects of other truncation mutations downstream of R161 (PMID: 14691445), is predicted to lead to a loss of Vhl protein function. | |
R161G | missense | loss of function - predicted | VHL R161G lies within the Elongin BC complex-interacting region of the Vhl protein (UniProt.org). R161G is predicted to confer a loss of function to the Vhl protein, as indicated by failure to bind to the elongin BC complex in an in vitro assay (PMID: 10587522). | |
R161L | missense | unknown | VHL R161L lies within the Elongin BC complex-interacting region of the Vhl protein (UniProt.org). R161L has not been characterized in the scientific literature and therefore, its effect on Vhl protein function is unknown (PubMed, Jun 2024). | |
R161P | missense | loss of function | VHL R161P lies within the Elongin BC complex interaction region of the Vhl protein (UniProt.org). R161P confers a loss of function to the Vhl protein as indicated by loss of binding to the elongin BC complex and destabilization of microtubule in culture (PMID: 10587522, PMID: 20855504). | |
R161Q | missense | unknown | VHL R161Q lies within the Elongin BC complex-interacting region of the Vhl protein (UniProt.org). R161Q results in a partial loss of binding to HIF-OH and partial degradation of Hif2a in culture (PMID: 25371412), but has not been fully biochemically characterized and therefore, its effect on Vhl protein function is unknown. | |
R167G | missense | unknown | VHL R167G does not lie within any known functional domains of the Vhl protein (UniProt.org). R167G has been identified in the scientific literature (PMID: 18836774), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, May 2024). | |
R167Q | missense | loss of function | VHL R167Q does not lie within any known functional domains of the Vhl protein (UniProt.org). R167Q leads to a loss of Vhl function as indicated by impaired Elongin C binding and inhibition of Hif2a expression in cell culture (PMID: 15574766). | |
R167W | missense | loss of function | VHL R167W does not lie within any known functional domains of the Vhl protein (UniProt.org). R167W confers a loss of function to the Vhl protein as demonstrated by decreased binding to Elongin BC and Cul2 (PMID: 9122164, PMID: 9651579) and impaired ubiquitination and degradation of Esr1 (ER-alpha) in cultured cells (PMID: 23159849). | |
R177fs | frameshift | loss of function - predicted | VHL R177fs results in a change in the amino acid sequence of the Vhl protein beginning at aa 177 of 213, likely resulting in premature truncation of the functional protein (UniProt.org). R177fs has not been characterized, however, due to the effects of other truncation mutations downstream of R177 (PMID: 14691445), is predicted to lead to a loss of Vhl protein function. | |
R205C | missense | unknown | VHL R205C does not lie within any known functional domains of the Vhl protein (UniProt.org). R205C has not been characterized in the scientific literature and therefore, its effect on Vhl protein function is unknown (PubMed, May 2024). | |
R205H | missense | unknown | VHL R205H does not lie within any known functional domains of the Vhl protein (UniProt.org). R205H has been identified in sequencing studies (PMID: 29506494, PMID: 22895193, PMID: 28422758), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, Apr 2024). | |
R64P | missense | loss of function - predicted | VHL R64P does not lie within any known functional domains of the Vhl protein (UniProt.org). R64P demonstrates regulation of Hif2a and Glut1 similar to wild-type Vhl (PMID: 16452184, PMID: 16098468), however, results in disrupted fibronectin matrix assembly (PMID: 11331612, PMID: 16452184) and mitochondrial biogenesis (PMID: 35760869), increased Prkcz (aPKC) and Junb levels in cultured cells (PMID: 16098468), and increased tumor vascularization compared to controls in mouse models (PMID: 16452184), and therefore, is predicted to lead to a loss of Vhl protein function. | |
R69C | missense | loss of function | VHL R69C does not lie within any known functional domains of the Vhl protein (UniProt.org). R69C confers a loss of function to the Vhl protein as demonstrated by impaired binding to Hif1a in an in vitro assay and failure to mediate Hif2a degradation in cultured cells (PMID: 15611064). | |
R79G | missense | unknown | VHL R79G does not lie within any known functional domains of the Vhl protein (UniProt.org). R79G has been identified in sequencing studies (PMID: 30325992, PMID: 33720516), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, Apr 2024). | |
R79P | missense | unknown | VHL R79P does not lie within any known functional domains of the Vhl protein (UniProt.org). R79P has been identified in sequencing studies (PMID: 10766184), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, Apr 2024). | |
R79_S80del | deletion | unknown | VHL R79_S80del results in the deletion of two amino acids of the Vhl protein from amino acids 79 to 80 (UniProt.org). R79_S80del has not been characterized in the scientific literature and therefore, its effect on Vhl protein function is unknown (PubMed, Jun 2024). | |
R82P | missense | loss of function | VHL R82P does not lie within any known functional domains of the Vhl protein (UniProt.org). R82P confers a loss of function to the Vhl protein as demonstrated by loss of binding to Vdu1 and impaired ubiquitination of Vdu1 in cell culture (PMID: 11739384). | |
S111N | missense | loss of function | VHL S111N lies within the CCT complex-binding region of the Vhl protein (UniProt.org). S111N leads to a loss of Vhl function as indicated by impaired binding to Hif-alpha and inhibition of Hif1a ubiquitination (PMID: 10878807). | |
S111P | missense | unknown | VHL S111P lies within the CCT complex-binding region of the Vhl protein (UniProt.org). S111P has not been characterized in the scientific literature and therefore, its effect on Vhl protein function is unknown (PubMed, Jun 2024). | |
S111R | missense | loss of function | VHL S111R lies within the CCT complex-binding region of the Vhl protein (UniProt.org). S111R leads to a loss of Vhl function as indicated by impaired binding to Hif1a, p300 and Tip60, and failure to transactivate p53 on DNA damage in cell culture (PMID: 22071692). | |
S139fs | frameshift | loss of function - predicted | VHL S139fs results in a change in the amino acid sequence of the Vhl protein beginning at aa 139 of 213, likely resulting in premature truncation of the functional protein (UniProt.org). S139fs has not been characterized, however, due to the effects of other truncation mutations downstream of S139 (PMID: 14691445), is predicted to lead to a loss of Vhl protein function. | |
S183L | missense | loss of function | VHL S183L does not lie within any known functional domains of the Vhl protein (UniProt.org). S183L confers a loss of function to the Vhl protein as indicated by decreased Vhl protein stability, impaired ability to regulate Hif1a degradation, and increased expression of Hif1a target genes in cultured cells (PMID: 21454469). | |
S38F | missense | unknown | VHL S38F lies within the pentameric repeat region of the Vhl protein (UniProt.org). S38F has been identified in sequencing studies (PMID: 15932632), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, May 2024). | |
S65* | nonsense | loss of function - predicted | VHL S65* results in a premature truncation of the Vhl protein at amino acid 65 of 213 (UniProt.org). S65* has not been characterized, however, due to the effects of other truncation mutations downstream of S65 (PMID: 14691445), is predicted to lead to a loss of Vhl protein function. | |
S65L | missense | loss of function | VHL S65L does not lie within any known functional domains of the Vhl protein (UniProt.org). S65L confers a loss of function to the Vhl protein as demonstrated by impaired binding to Hif1a in an in vitro assay and failure to mediate Hif2a degradation in cultured cells (PMID: 15611064). | |
S65P | missense | loss of function | VHL S65P does not lie within any known functional domains of the Vhl protein (UniProt.org). S65P results in reduced Vhl protein stability and impaired binding to Hif2a, leading to increased Hif2a stability, upregulation of EMT markers, and increased migration and invasion in cell culture (PMID: 35505422). | |
S65T | missense | unknown | VHL S65T does not lie within any known functional domains of the Vhl protein (UniProt.org). S65T has been identified in sequencing studies (PMID: 23606570), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, Jun 2024). | |
S65W | missense | loss of function | VHL S65W does not lie within any known domains of the Vhl protein (UniProt.org). S65W results in reduced Vhl protein stability and impaired binding to Hif2a, leading to increased Hif2a stability, upregulation of EMT markers, and increased migration and invasion in cell culture (PMID: 15611064, PMID: 35505422). | |
S68* | nonsense | loss of function - predicted | VHL S68* results in a premature truncation of the Vhl protein at amino acid 68 of 213 (UniProt.org). S68* has not been characterized, however, due to the effects of other truncation mutations downstream of S68 (PMID: 14691445), is predicted to lead to a loss of Vhl protein function. | |
S68fs | frameshift | loss of function - predicted | VHL S68fs results in a change in the amino acid sequence of the Vhl protein beginning at aa 68 of 213, likely resulting in premature truncation of the functional protein (UniProt.org). S68fs has not been characterized, however, due to the effects of other truncation mutations downstream of S68 (PMID: 14691445), is predicted to lead to a loss of Vhl protein function. | |
S68P | missense | unknown | VHL S68P does not lie within any known functional domains of the Vhl protein (UniProt.org). S68P has been identified in the scientific literature (PMID: 27785399, PMID: 17661816), but has not been biochemically characterized and therefore, its effect on VHL protein function is unknown (PubMed, Jun 2024). | |
S68W | missense | loss of function | VHL S68W does not lie within any known domains of the Vhl protein (UniProt.org). S68W confers a loss of function to the Vhl protein as demonstrated by impaired binding to Hif1a in an in vitro assay and failure to mediate Hif2a degradation in cultured cells (PMID: 15611064). | |
S80I | missense | unknown | VHL S80I does not lie within any known functional domains of the Vhl protein (UniProt.org). S80I has been identified in the scientific literature (PMID: 24678776, PMID: 25563310), but has not been biochemically characterized and therefore, its effect on VHL protein function is unknown (PubMed, Apr 2024). | |
S80N | missense | unknown | VHL S80N does not lie within any known functional domains of the Vhl protein (UniProt.org). S80N has been identified in the scientific literature (PMID: 22683710, PMID: 23797736, PMID: 26895810), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, May 2024). | |
S80R | missense | unknown | VHL S80R does not lie within any known functional domains of the Vhl protein (UniProt.org). S80R has been identified in the scientific literature (PMID: 35350224, PMID: 38422612, PMID: 35110537), but has not been biochemically characterized and therefore, its effect on VHL protein function is unknown (PubMed, Jun 2024). | |
T100A | missense | unknown | VHL T100A lies within the CCT-complex binding region of the Vhl protein (UniProt.org). T100A has been identified in the scientific literature (PMID: 32043779), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, Apr 2024). | |
T133fs | frameshift | loss of function - predicted | VHL T133fs results in a change in the amino acid sequence of the Vhl protein beginning at aa 133 of 213, likely resulting in premature truncation of the functional protein (UniProt.org). T133fs has not been characterized, however, due to the effects of other truncation mutations downstream of T133 (PMID: 14691445), is predicted to lead to a loss of Vhl protein function. | |
T202* | nonsense | loss of function | VHL T202* results in a premature truncation of the Vhl protein at amino acid 202 of 213 (UniProt.org). T202* results in reduced Hif1a binding in low salt conditions and decreased Hif1a ubiquitination efficiency, and leads to increased Hif1a and Glut1 expression levels under hypoxic conditions in cell culture (PMID: 14691445). | |
V130D | missense | unknown | VHL V130D lies within the CCT complex-binding region of the Vhl protein (UniProt.org). V130D has been identified in sequencing studies (PMID: 25691774), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, Jun 2024). | |
V130F | missense | unknown | VHL V130F lies within the CCT complex-binding region of the Vhl protein (UniProt.org). V130F is predicted to lead to destabilizing of Vhl by computational modeling (PMID: 19408289), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, Jun 2024). | |
V155A | missense | loss of function - predicted | VHL V155A lies within the CCT complex-binding region of the Vhl protein (UniProt.org). V155A retains the ability to bind the Elongin BC complex and ubiquitinate Hif1a in in vitro assays (PMID: 26503325), however, is predicted to lead to a loss of Vhl protein function as demonstrated by increased ubiquitination by Ube2s leading to reduced Vhl protein stability and impaired ability to adequately regulate Hif protein expression and activity in in vitro assays and cell culture (PMID: 26503325). | |
V155fs | frameshift | loss of function - predicted | VHL V155fs results in a change in the amino acid sequence of the Vhl protein beginning at aa 155 of 213, likely resulting in premature truncation of the functional protein (UniProt.org). V155fs has not been characterized, however, due to the effects of other truncation mutations downstream of V155 (PMID: 14691445), is predicted to lead to a loss of Vhl protein function. | |
V155M | missense | unknown | VHL V155M lies within the CCT complex-binding region of the Vhl protein (UniProt.org). V155M has been identified in sequencing studies (PMID: 28893800, PMID: 24471421), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, May 2024). | |
V165D | missense | unknown | VHL V165D lies within the Elongin BC complex-interacting region of the Vhl protein (UniProt.org). V165D has been identified in sequencing studies (PMID: 24727139, PMID: 36515470), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, Jun 2024). | |
V166F | missense | loss of function - predicted | VHL V166F lies within the Elongin BC complex-interacting region of the Vhl protein (UniProt.org). V166F results in reduced binding to elongin B and Cul2 in cell culture (PMID: 10587522), and therefore, is predicted to lead to a loss of Vhl protein function. | |
V62fs | frameshift | loss of function - predicted | VHL V62fs results in a change in the amino acid sequence of the Vhl protein beginning at aa 62 of 213, likely resulting in premature truncation of the functional protein (UniProt.org). V62fs has not been characterized, however, due to the effects of other truncation mutations downstream of V62 (PMID: 14691445), is predicted to lead to a loss of Vhl protein function. | |
V74D | missense | unknown | VHL V74D does not lie within any known functional domains of the Vhl protein (UniProt.org). V74D has been identified in sequencing studies (PMID: 24446253, PMID: 28481359), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, May 2024). | |
V74G | missense | unknown | VHL V74G does not lie within any known functional domains of the Vhl protein (UniProt.org). V74G has been identified in the scientific literature (PMID: 18836774, PMID: 21710693), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, Apr 2024). | |
W117* | nonsense | loss of function - predicted | VHL W117* results in a premature truncation of the Vhl protein at amino acid 117 of 213 (UniProt.org). W117* has not been characterized, however, is associated with resistance to BET inhibitors in culture (PMID: 36329119) and due to the effects of other truncation mutations downstream of W117 (PMID: 14691445), is predicted to lead to a loss of Vhl protein function. | Y |
W117C | missense | loss of function | VHL W117C lies within the CCT complex-binding region of the Vhl protein (UniProt.org). W117C confers a loss of function to the Vhl protein as demonstrated by weak binding with CCT resulting in improper folding of the VHL-elongin BC complex (PMID: 14636579). | |
W117L | missense | unknown | VHL W117L lies within the CCT complex-binding region of the Vhl protein (UniProt.org). W117L has been identified in the scientific literature (PMID: 22158988, PMID: 16488999), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, Jun 2024). | |
W117R | missense | loss of function | VHL W117R lies within the CCT complex-binding region of the Vhl protein (UniProt.org). W117R confers a loss of function to the Vhl protein as demonstrated by disrupted fibronectin matrix assembly (PMID: 9651579), decreased Hif1a binding and ubiquitination in in vitro assays (PMID: 11865071), and elevated Hif2a and Glut1 expression in normoxic conditions (PMID: 11865071, PMID: 17526729) and increased cell proliferation under low serum conditions in culture (PMID: 17526729). | |
W88* | nonsense | loss of function - predicted | VHL W88* results in a premature truncation of the Vhl protein at amino acid 88 of 213 (UniProt.org). W88* has not been characterized, however, due to the effects of other truncation mutations downstream of W88 (PMID: 14691445), is predicted to lead to a loss of Vhl protein function. | |
W88C | missense | unknown | VHL W88C does not lie within any known functional domains of the Vhl protein (UniProt.org). W88C has been identified in sequencing studies (PMID: 10567493), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, Apr 2024). | |
W88L | missense | unknown | VHL W88L does not lie within any known functional domains of the Vhl protein (UniProt.org). W88L has been identified in sequencing studies (PMID: 24727139, PMID: 29118224), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, May 2024). | |
W88R | missense | unknown | VHL W88R does not lie within any known functional domains of the Vhl protein (UniProt.org). W88R has been identified in sequencing studies (PMID: 23036577), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, May 2024). | |
wild-type | none | no effect | Wild-type VHL indicates that no mutation has been detected within the VHL gene. | |
Y112* | nonsense | loss of function - predicted | VHL Y112* results in a premature truncation of the Vhl protein at amino acid 112 of 213 (UniProt.org). Y112* has not been characterized, however, due to the effects of other truncation mutations downstream of Y112 (PMID: 14691445), is predicted to lead to a loss of Vhl protein function. | |
Y112C | missense | unknown | VHL Y112C lies within the CCT complex-binding region of the Vhl protein (UniProt.org). Y112C has been demonstrated to confer resistance to BET inhibitors in culture (PMID: 36329119), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, Jun 2024). | Y |
Y112D | missense | no effect - predicted | VHL Y112D lies within the CCT complex-binding region of the Vhl protein (UniProt.org). Y112D results in microtubule stability (PMID: 12510195) and regulation of E2f1 expression similar to wild-type Vhl in culture (PMID: 23744542), and therefore, is predicted to have no effect on Vhl protein function. | |
Y112H | missense | loss of function | VHL Y112H lies within the CCT complex-binding region of the Vhl protein (UniProt.org). Y112H confers a loss of function to the Vhl protein as demonstrated by decreased stability and impaired regulation of Hif1-alpha activity in culture (PMID: 16261165, PMID: 19030229). | |
Y112N | missense | loss of function | VHL Y112N lies within the CCT complex-binding region of the Vhl protein (UniProt.org). Y112N confers a loss of function to the Vhl protein as demonstrated by reduced stability of the Vhl-Elongin B/C complex (PMID: 16261165), decreased Hif1a ubiquitination in in vitro assays (PMID: 16261165, PMID: 16407835), elevated Hif2a, Glut1, and cyclin D1 expression in normoxic conditions (PMID: 16407835, PMID: 17526729), increased cell proliferation in low serum conditions in culture (PMID: 17526729), and promotion of tumor formation in animal models (PMID: 17526729). | |
Y175* | nonsense | loss of function - predicted | VHL Y175* results in a premature truncation of the Vhl protein at amino acid 175 of 213 (UniProt.org). Y175* has not been characterized, however, due to the effects of other truncation mutations downstream of Y175 (PMID: 14691445), is predicted to lead to a loss of Vhl protein function. | |
Y98C | missense | unknown | VHL Y98C does not lie within any known functional domains of the Vhl protein (UniProt.org). Y98C has been identified in the scientific literature (PMID: 22799452), but has not been biochemically characterized and therefore, its effect on Vhl protein function is unknown (PubMed, May 2024). | |
Y98H | missense | loss of function | VHL Y98H does not lie within any known functional domains of the Vhl protein (UniProt.org). Y98H confers a loss of function to the Vhl protein as demonstrated by impaired Hif1a ubiquitination (PMID: 11331612) and defective microtubule stabilization in cultured cells (PMID: 12510195). | |
Y98N | missense | loss of function | VHL Y98N does not lie within any known functional domains of the Vhl protein (UniProt.org). Y98N confers a loss of function to the Vhl protein as demonstrated by failure to completely suppress Glut1 and defects in Hif1-alpha ubiquitination (PMID: 10823831). |